Evaluation of Streptococcus Pneumoniae Nasopharyngeal Carriage Rate in Children Receiving Pneumococcal Conjugated Vaccine (Prevnar) Under the Auspices of the Taipei City Government Vaccination Program
Phase of Trial: Phase IV
Latest Information Update: 19 Dec 2007
At a glance
- Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- Sponsors Wyeth
- 19 Dec 2007 Status changed from in progress to completed according to ClinicalTrials.gov.
- 16 Jul 2007 New trial record.